BeaconEquity.com announces the publication of an article covering Chuck Panozzo’s advocacy for GeoVax Labs’ HIV/AIDS vaccine, and his hope for affordability and accessibility to all.
Investors can view all of the investment articles for free by visiting: http://www.beaconequity.com/m
In the article the author writes:
“GeoVax Labs Inc. (OTCBB: GOVX), a biopharmaceutical company developing vaccines for diseases caused by HIV-1, recently announced Chuck Panozzo, founder of the rock band Styx, has joined the company as an advocate for the company's HIV/AIDS vaccine, which is currently in phase IIa trials.”
The success of the GeoVax Labs’ HIV/AIDS vaccine will be measured by its affordability and accessibility, states Panozzo:
'
“The success of the company's vaccine will be measured by its affordability and accessibility to all, with adequate AIDS treatment presently only affordable to the well-insured and wealthy patients.”
To read the entire article visit http://www.beaconequity.com/m
Join the fastest growing investor community at: http://www.stockhideout.com/
BeaconEquity.com’s Market News is one of the fastest growing small cap blogs in the investment community. Beacon is the authority on research in the small cap sector, and our analysts strive each day to find the stocks that are poised to be the biggest movers before the rest of the market is aware of them.
We encourage investors to subscribe to our FREE newsletter filled with daily trading ideas.
BeaconEquity.com is one of the industry’s largest small cap research providers. Beacon strives to provide a balanced view of many promising small cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the publicly available information available on them. For more information on Beacon Research, please visit: http://www.beaconequity.com/m
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. BeaconEquity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Source: BeaconEquity.com
Beacon Equity Research
Jeff Bishop, (469)-252-3505
press@beaconequity.com
